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Abstract
Background: Limiting consumption of eggs, which are high in cholesterol, is generally recommended to reduce risk of 
cardiovascular disease. However, recent evidence suggests that dietary cholesterol has limited influence on serum 
cholesterol or cardiac risk.
Objective: To assess the effects of egg consumption on endothelial function and serum lipids in hyperlipidemic adults.
Methods: Randomized, placebo-controlled crossover trial of 40 hyperlipidemic adults (24 women, 16 men; average 
age = 59.9 ± 9.6 years; weight = 76.3 ± 21.8 kilograms; total cholesterol = 244 ± 24 mg/dL). In the acute phase, 
participants were randomly assigned to one of the two sequences of a single dose of three medium hardboiled eggs 
and a sausage/cheese breakfast sandwich. In the sustained phase, participants were then randomly assigned to one of 
the two sequences of two medium hardboiled eggs and 1/2 cup of egg substitute daily for six weeks. Each treatment 
assignment was separated by a four-week washout period. Outcome measures of interest were endothelial function 
measured as flow mediated dilatation (FMD) and lipid panel.
Results: Single dose egg consumption had no effects on endothelial function as compared to sausage/cheese (0.4 ± 
1.9 vs. 0.4 ± 2.4%; p = 0.99). Daily consumption of egg substitute for 6 weeks significantly improved endothelial 
function as compared to egg (1.0 ± 1.2% vs. -0.1 ± 1.5%; p < 0.01) and lowered serum total cholesterol (-18 ± 18 vs. -5 ± 
21 mg/dL; p < 0.01) and LDL (-14 ± 20 vs. -2 ± 19 mg/dL; p = 0.01). Study results (positive or negative) are expressed in 
terms of change relative to baseline.
Conclusions: Egg consumption was found to be non-detrimental to endothelial function and serum lipids in 
hyperlipidemic adults, while egg substitute consumption was beneficial.
Background
As of the early 1970's, a reduction in consumption of
eggs, a concentrated source of cholesterol (one yolk pro-
vides ~215 mg of cholesterol), had been widely recom-
mended in an effort to lower blood cholesterol and
reduce the risk of heart disease[1]. In 1973, the American
Heart Association (AHA) guidelines specifically advo-
cated exclusion of eggs from the diet, accompanying the
advised cholesterol restriction[2]. More recent AHA
guidelines no longer advise for or against egg or egg yolk
consumption, admitting that there is a lack of scientific
evidence for selecting a target level for dietary choles-
terol[3]. This is partially due to individual differences in
serum cholesterol responses to dietary cholesterol. The
recommended intake of daily dietary cholesterol contin-
ues to be 300 mg/day or less for healthy adults and less
than 200 mg/day for persons with elevated cholesterol or
heart disease[3]. Given the widespread nature of this rec-
ommendation, there is surprisingly little evidence that
egg consumption increases blood cholesterol levels,
thereby increasing cardiovascular risk [4].
Data from recent studies show that consumption of one
or two eggs per day, when part of a low fat diet, does not
adversely affect the lipid profile[5,6]. In fact, the preclu-
sion of eggs from the diet may represent a potential
reduction in overall dietary quality. As an inexpensive
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functional food with an exceptional nutritional pro-
file[7,8], eggs are an excellent natural source of folate,
riboflavin, selenium, choline, vitamin B12, and fat-soluble
vitamins A, D, E, and K. Eggs also provide high-quality,
bioavailable protein[9,10] with little total fat. Compared
to other animal protein sources, eggs contain proportion-
ately less saturated fat, which has generally been recog-
nized as a strong dietary determinant of elevated low-
density lipoprotein (LDL) levels and increased risk of cor-
onary heart disease (CHD) [11] although this topic is not
without controversy [12].
As a dietary substitute for eggs, egg substitute is com-
prised of 99% egg whites and provide 12 key vitamins and
nutrients, including riboflavin, B12, folate, and pantoth-
enic acid, while excluding the cholesterol contribution of
the egg yolk[13]. Although nutritionally similar to eggs,
egg substitute contains emulsifiers, stabilizers, and artifi-
cial color and are on average three times as expensive as
regular eggs.
Endothelial function refers to arterial vasomotor
responses mediated predominantly by the release of
nitric oxide (vasodilating), and endothelin (vasoconstrict-
ing) from the vascular endothelium[14,15], and plays an
important role in the pathogenesis of atherosclerosis,
hypertension, cardiovascular disease, and diabetes[15-
17]. Endothelial dysfunction correlates strongly with both
coronary disease and its risk factors[18,19] and reverses
in response to risk modification efforts[15,20-27].
Endothelial dysfunction has increasingly been viewed as
an indicator of coronary risk[19], and its amelioration as
an indicator of risk reduction[20,23].
The relationship of egg consumption to coronary out-
comes depends not only on the cholesterol content of
eggs themselves, but on the composition of the total diet.
It is a common misconception that dietary cholesterol
increases serum cholesterol which increases CHD
risk[28,29]; however, research has failed to provide sub-
stantial evidence of this assumed relationship[30]. In our
previous trial, daily ingestion of eggs did not produce
adverse effects on cardiac risk, as indicated by endothelial
function and lipid profile, in healthy adults[31]. To the
best of our knowledge, no study has ever compared the
effects of egg versus egg substitute consumption on car-
diovascular risk. Therefore, we performed a randomized
cross-over trial to assess the effects of egg or egg substi-
tute consumption on endothelial function and lipid panel
in hyperlipidemic adults.
Subjects and Methods
Subjects
Forty adults (16 men and 24 women) with diagnosed
hyperlipidemia were recruited from Southwestern Con-
necticut; largely through mass media print advertise-
ments and posters. Eligible subjects were 35 years of age
or older if they were male or post-menopausal and not
currently using hormone replacement therapy if they
were female. Additionally, eligible subjects were non-
smokers, and hyperlipidemic as defined by serum total
cholesterol >240 mg/dL, and/or LDL cholesterol >160
mg/dL, and/or a total cholesterol/HDL ratio >5.7. All eth-
nic and minority groups were equally eligible. Individuals
with a current eating disorder, a restricted diet, diagnosed
coronary disease, diabetes, or sleep apnea were excluded
from the study. Additional exclusion criteria included the
regular use of lipid-lowering medication, insulin or glu-
cose sensitizing medication, vasoactive medication or
nutriceuticals, high dose vitamin E or C, and fiber supple-
ments.
Individuals who responded to recruitment efforts (n =
172) were pre-screened using a semi-structured tele-
phone interview. Those who met initial screening criteria
(n = 40) underwent a clinical screening evaluation
(weight, height, body mass index (BMI), and blood pres-
sure measurements) performed by a clinical research spe-
cialist, along with laboratory testing (fasting total
cholesterol, HDL, LDL, and triglycerides levels) (Figure
1).
All participants provided informed consent and were
compensated monetarily for their time. The study proto-
col was approved by the Institutional Review Board (IRB)
of Griffin Hospital (Derby, CT).
Study Design
This study was a randomized, single-blind crossover trial
with investigators blinded to treatment assignments. The
trial consisted of an acute and a sustained phase. In the
acute phase, 40 participants were randomly assigned to
consume one of the two sequence permutations of a sin-
gle dose of breakfast of three medium hardboiled eggs
and a sausage/cheese breakfast sandwich (Table 1). In the
sustained phase, participants were randomly assigned to
one of the two sequence permutations of two medium
hardboiled eggs and 1/2 cup of egg substitute breakfast
daily for six weeks. Randomization was conducted by the
data manager using a SAS (SAS version 9.1; SAS Institute,
Cary, NC) algorithm. Each treatment assignment was
separated by a four-week washout period. The study par-
ticipants fasted overnight before undergoing endothelial
function assessment. Due to the obvious dietary makeup
of each treatment assignment, it was not possible to blind
participants to their assignment; however, the ultra-
sonographer was strictly blinded to participants' treat-
ment assignment.
Outcome Measures
Endothelial Function Assessment
The brachial artery reactivity studies (BARS) methodol-
ogy employed is comparable to those of other leadingNjike et al. Nutrition Journal 2010, 9:28
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Figure 1 Flow of Participants through the Trial.
172 Responded to Recruiting Advertisements 
40 Completed Acute Phase of Trial 
36 Completed Sustained Phase of Trial 
132 Excluded 
     122 Not eligible on prescreening criteria  
     10 Refused to participate 
Potential participants to be randomized (n=40) 
Acute Phase (n=40) 
Eggs (n=20) 
Sausage & Cheese (n=20) 
4-week washout 
Sausage & Cheese (n=20) 
Eggs (n=20) 
4-week washout 
Egg Substitute 
(n=20) 
Eggs (n=20) 
4-week washout  
Sustained Phase (n=40) 
Egg Substitute 
(n=20) 
4-week washout  
Eggs (n=20) 
2 dropped out because they 
started statin 
1 dropped out due to relocation to 
another state Njike et al. Nutrition Journal 2010, 9:28
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labs[16,32-36], and is described in "Guidelines for ultra-
sound assessment of endothelial-dependent flow-medi-
ated vasodilation of the brachial artery"[16]. Participants
were required to lie at rest in the quiet, temperature-con-
trolled, softly lit room for at least 15 minutes before scan-
ning was initiated. The baseline diameter of the brachial
artery was measured from two-dimensional ultrasound
images using a high frequency, 10-15 MHz, vascular
ultrasound transducer (Sonos 4500; Phillips Medical Sys-
tems, Andover, MA). Arterial flow-velocity was mea-
sured by means of a pulsed Doppler signal at a 70° angle
to the vessel, with the range gate in the center of the
artery. Flow was determined by multiplying the arterial
cross-sectional area (πr2) by the Doppler flow velocity.
The timing of each image frame with respect to the car-
diac cycle was determined with simultaneous ECG gating
during image acquisition via the high-quality mainframe
ultrasound system. The arterial diameter was measured
at a fixed distance from an anatomical marker, such as a
bifurcation, with ultrasonic calipers. Measurements were
taken from the anterior to the posterior "m" line in dias-
tole. The brachial artery was imaged at a location 3-7 cm
above the antecubital fossa in the longitudinal plane. A
segment with clear anterior and posterior intimal inter-
faces between the lumen and vessel wall was selected for
continuous 2D gray scale imaging. The transmit (focus)
zone was set to the depth of the near wall because of diffi-
culty in differentiating the near from the far wall "m" line
(the interface between media and adventitia)[16,33].
Images were acquired on videotape and magnetic optical
disk for evaluation and analysis subsequent to the exami-
nation. Diameter was obtained from m-line to m-line,
over a consistent segment of vessel at least 10-15 mm in
length.
To create a flow stimulus in the brachial artery, a sphyg-
momanometer cuff was placed on the upper arm proxi-
mal to the transducer. A baseline blood flow and
diameter were acquired. Arterial occlusion was created
by cuff inflation to 50 mm Hg above the systolic blood
pressure. The cuff remains inflated for 5 minutes. This
causes ischemia and consequent dilation of downstream
resistance vessels via auto-regulatory mechanisms[16].
Cuff deflation induces a brief high-flow state through the
brachial artery (reactive hyperemia) to accommodate the
dilated resistance vessels. The resulting increase in shear
stress causes the normal brachial artery to dilate. A
pulsed Doppler signal was obtained within 15 seconds of
cuff release to assess hyperemic velocity, and a longitudi-
nal image of the artery was recorded continuously from
20 seconds to 2 minutes after cuff deflation. All images
were coordinated with a continuous ECG monitor and
obtained at end-diastole. The resultant coefficient of intra
observer reliability was 0.9.
Flow-mediated dilation (FMD) was measured as the
percent change in brachial artery diameter from pre-cuff
inflation to 60-seconds post-cuff release. In addition to
brachial diameter at 60 seconds post-cuff release, flow
after cuff deflation within the first 15 seconds was used as
an indicator of stimulus strength, hyperemic flow being
the stimulus for endothelial reactivity. To account for
potential variability in stimulus strength, FMD was
divided by flow at 15 seconds[16]. post-cuff deflation to
create a stimulus-adjusted response measure[31,37,38].
Lipid Profile Serum was drawn for lipid assessments
about twenty minutes prior to endothelial function
assessment. The lipid profile was determined as follows:
Total cholesterol (Tchol), triglycerides (TRIG), and high-
density lipoprotein (HDL) were obtained by direct mea-
surements. Very-low-density lipoprotein (VLDL) and
low-density-lipoprotein (LDL) were obtained by calcula-
tion: VLDL = TRIG/5; and LDL = Tchol - (VLDL + HDL)
[39].
Body Weight B o d y  w e i g h t  w a s  m e a s u r e d  f o r  a l l  s t u d y
participants at the beginning and end of the sustained
phase. Body weight was measured to the nearest 0.5
pound using a balance-type medical scale. Participants
were measured in the morning, unclothed with the
exception of undergarments.
Blood Pressure Blood pressure was determined with the
use of the Datascope Accutorr Plus automatic digital
blood pressure device (Datascope Corp, Mahwah, NJ)
with the participant supine after a 5-min period of rest.
Both systolic and diastolic pressures were calculated as
the mean value of 2 readings 5 minutes apart. All mea-
surements were obtained by one investigator.
Table 1: Composition of the Breakfasts in the Acute Phase
Nutrition Content Sausage & Cheese 3 Medium Eggs
Calories (kcal) 310 189
Calories from fat (Kcal) 260 118
Fat (gm) 29 13
Saturated fat (gm) 12 4
Sodium (mg) 720 185
Protein (g) 13 17
Calories from protein (kcal) 52 66
Carbohydrate (g) 0 1Njike et al. Nutrition Journal 2010, 9:28
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Statistical Analysis
Statistical analysis was conducted using SAS software
(Version 9.1, SAS Institute, Cary, NC). A two-tailed p-
value of ≤ 0.05 was considered statistically significant.
Two-way repeated measures ANOVA, with treatment
and time as the main effects, were performed to compare
treatment-specific outcome measures responses,
accounting for time differences. Within-treatment effects
for outcome measures were assessed using paired t-tests.
The combined effect of independent variables (age, blood
pressure, LDL, BMI and treatment sequence) and treat-
ment assignment on all outcome measures was assessed
with generalized linear modeling. All analyses of end-
points were based on the intention-to-treat principle.
Sample size was predicated on 80% power to detect a
minimal difference of 3.5% change in FMD between the
egg and egg substitute treatments at six weeks. A two-
tailed alpha level of 0.05 was set with an allowance for
10% attrition and noncompliance.
Results
Forty hyperlipidemic participants participated in this
study. Sixty percent of the participants were female. Par-
ticipants ranged in age from 35 to 77 years, with a mean
age of 60 years (Table 2). Four participants dropped out of
the study after the acute phase. One participant dropped
out because the participant was unwilling to consume
eggs or egg substitute daily for six weeks, another
dropped out because of relocation to another state, and
two dropped out because they started using lipid lower-
ing medication (statin).
Acute Phase
After a single dose of eggs, endothelial function did not
change from baseline as compared to sausage and cheese
( p = 0.99). Accounting for the strength of the stimulus
that determines vasodilatations (SARM), our findings on
endothelial function persisted (Table 3.)
Sustained Phase
Daily consumption of egg substitute for six weeks
improved endothelial function relative to egg consump-
tion ( p < 0.01). These findings persisted controlling for
the variation of the strength of the stimulus that causes
the vasodilatation (Table 4.)
Daily consumption of egg substitute for six weeks sig-
nificantly lowered total cholesterol as compared to egg
consumption ( p < 0.01) and also lowered LDL as com-
pared to egg consumption ( p = 0.01). However, daily con-
sumption of egg substitute for six weeks did not
significantly lowered total cholesterol to HDL ratio as
compared to egg consumption ( p = 0.38).
Daily consumption of egg or egg substitute for six
weeks did not show significant increase in BMI as com-
pared to egg consumption (p = 0.56)
Discussion
Our findings in this study expand on existing evidence
that short-term egg consumption does not adversely
affect endothelial function, in a population not previously
examined: hyperlipidemic adults. Moreover, we observed
that consuming eggs daily did not unfavorably influence
serum cholesterol or other measures of the lipid profile.
While the subjects demonstrated impaired endothelial
function at baseline (i.e. relative to healthy endothelial
function), the acute induction of endothelial dysfunction
by the test meal high in saturated fat was not observed.
Egg substitute, which is made from 99% egg whites, is
lower in calories relative to whole eggs, lacks cholesterol
and fat, and is fortified with vitamins, also lowered cho-
lesterol and triglyceride levels. In addition, egg substitute
led to a decrease in LDL and significantly improved
endothelial function, as compared to sustained egg con-
sumption. To the best of our knowledge, this is the first
study to provide evidence that egg or egg substitute con-
sumption does not adversely affect endothelial function
in hyperlipidemic adults.
The acute phase findings were consistent with those of
the sustained phase. Single, acute doses of egg did not
adversely affect endothelial function. The sausage and
cheese breakfast sandwich, designed to demonstrate
acute dysfunction in the endothelium, surprisingly also
did not adversely affect endothelial function. This finding
is consistent with the prior study of egg ingestion in
healthy adults conducted at our lab[31], but is at odds
with the reported literature. This may be explained by
Table 2: Demographic and Baseline Characteristics
Variable Values Range
Gender
Female 24 (60%)
Male 16 (40%)
Race
White 39 (97.5%)
African American 1 (2.5%)
Age (years) 59.9 ± 9.6 35 to 77
Brachial Artery Diameter (mm) 4.0 ± 0.8 2.8 to 5.4
Systolic Blood Pressure (mmHg) 131.4 ± 15.7 94 to 173
Diastolic Blood Pressure (mmHg) 73.0 ± 12.6 45 to 105
Framingham 10-years Risk (%) 6.6 ± 5.8 1 to 30
Body Mass Index (kg/m2) 28.7 ± 4.7 20.4 to 38.4
Weight (kg) 76.3 ± 21.8 45 to 105
Values are mean ± SD except otherwise statedNjike et al. Nutrition Journal 2010, 9:28
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differences in gastric transit times for different types of
food [31]. Future studies should evaluate postprandial
brachial artery dilation at different time points to assess
the effect of time. Several studies have examined FMD
serially over time following meal ingestion[40,41].
While rich in cholesterol, eggs are also nutritious. Data
from NHANES III reveal that egg consumption is an
important nutritional contribution to the average Ameri-
can diet, providing a relatively inexpensive source of
amino acids and essential fatty acids[9]. Eggs provide
arginine, a precursor to nitric oxide, which in turn plays a
central role in endothelial function[42]. Endothelial func-
tion is an arterial vasomotor response mediated predomi-
nantly by the release of nitric oxide (vasodilating), and
endothelin (vasoconstricting) from the vascular endothe-
lium[26]. This system plays an important role in the
pathogenesis of atherosclerosis, cardiovascular disease,
and other chronic diseases[19,43].
The relative importance of dietary cholesterol to car-
diovascular risk, and the association between dietary and
serum cholesterol, are both subject to ongoing debate[44-
46]. The association between dietary cholesterol and cor-
onary events and mortality is generally positive but rather
weak, and derived largely from ecological and prospec-
tive cohort studies with variable follow-up[47-50]. In
most of these studies, it is difficult to determine the
effects of cholesterol independent of dietary fat. One
large prospective cohort followed U.S. male physicians
for over 20 years. The study monitored egg consumption
and documented new cases of heart failure during follow-
up. Results failed to find a correlation between occasional
egg consumption and heart failure, although an increased
risk of heart failure was related to participants who
reported consuming more than one egg per day[49].
Another study found no impact of egg intake on cardio-
vascular risk, specifically stroke, ischemic stroke, and
coronary artery disease. However, Nakamura et al dem-
onstrated significant correlation with serum cholesterol
concentrations in women consuming more than two eggs
per day [51]. In a recent study by Djoussé et al, egg con-
sumption was associated with increased risk of diabetes
[52]. Djoussé et al also linked egg consumption to
increased mortality and even more so in diabetics [53].
Overall, scientific studies of the relationship between egg
consumption, cardiovascular disease and mortal-
ity[30,54], have thus been somewhat inconsistent.
Little, if any, epidemiological evidence exists support-
ing a direct link between egg consumption and cardiovas-
cular disease or mortality risk. Previous studies have
shown weak positive associations between intake of
dietary cholesterol and serum cholesterol, while others
failed to find any association[30]. Hu and colleagues ana-
lyzed data from two large cohorts, the Health Profes-
sional Follow-Up Study and the Nurses' Health Study, to
assess the effect of egg consumption on cardiovascular
events and deaths[47]. After a mean of 8 years of follow-
up, no overall significant association was observed
between egg consumption and risk of CHD in both males
and females. Hu et al [47] also reported that the relative
risk of CHD was the same whether the participants con-
sumed less than, or more than, one egg per week.
While our study provides valuable data regarding egg
ingestion in hyperlipidemic adults, it is not without limi-
tations. The study's small sample size almost entirely
derived from one community in Southwestern Connecti-
cut may limit the generalization these of results. Further-
more, the duration of egg consumption during this study
limits the ability to predict the long-term effects. Vari-
Table 3: Acute Phase: Mean change in Outcome Measures after Treatment Assignment
Variable Egg (n = 40) Sausage & Cheese (n = 40) p-value
Baseline Brachial Artery Diameter (mm) 4.0 ± 0.8 4.0 ± 0.7 0.79*
Flow Mediated Dilatation (%)
Baseline 5.9 ± 4.6 5.2 ± 3.6 0.45*
Post-prandial 6.3 ± 5.3 5.6 ± 4.5
Change 0.4 ± 1.9 (P = 0.22) 0.4 ± 2.4 (P = 0.34) 0.99
Adjusted change† 0.3 ± 2.1 (P = 0.46) 0.4 ± 2.1 (P = 0.31) 0.84
Stimulus adjusted response measure
Baseline 0.10 ± 0.12 0.06 ± 0.06 0.05*
Post-prandial 0.08 ± 0.09 0.07 ± 0.06
Change -0.02 ± 0.11 (P = 0.31) 0.00 ± 0.08 (P = 0.89) 0.35
Values are mean ± SD; p-value obtained from ANOVA for repeated measurements except otherwise stated; Change = Post-prandial - Baseline; 
*p-value obtain from Student's t-test; p-values in parenthesis indicate within-group p-values; † obtained from generalized linear models, 
controlling for age, blood pressure, LDL and BMINjike et al. Nutrition Journal 2010, 9:28
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Table 4: Sustained Phase: Mean Change in Outcome Measures after Six Weeks of Treatment
Variable Egg (n = 36) Egg substitute (n = 36) p-value
Endothelial Function
Flow Mediated Dilatation (%)
Baseline 5.6 ± 3.9 5.8 ± 3.9 0.78
6 Weeks 5.3 ± 4.1 6.9 ± 4.0
Change -0.1 ± 1.5 (P = 0.80) 1.0 ± 1.2 (P < 0.01) <0.01
Adjusted change† -0.2 ± 1.3 (P = 0.35) 0.9 ± 1.4 (P < 0.01) < 0.01
Stimulus adjusted response measure
Baseline 0.08 ± 0.10 0.06 ± 0.06 0.39
6 Weeks 0.08 ± 0.11 0.09 ± 0.09
Change 0.01 ± 0.05 (P = 0.54) 0.03 ± 0.06 (P < 0.01) 0.07
Lipid Panel
Total Cholesterol (mg/dL)
Baseline 244 ± 24 244 ± 24 1.00
6 Weeks 239 ± 27 227 ± 27
Change -5 ± 21 (P = 0.10) -18 ± 18 (P < 0.01) < 0.01
Low Density Lipoprotein (mg/dL)
Baseline 168 ± 17 168 ± 17
6 Weeks 165 ± 24 154 ± 24
Change -2 ± 19 (P = 0.30) -14 ± 20 (P < 0.01) 0.01
High Density Lipoprotein (mg/dL)
Baseline 52 ± 15 52 ± 15 1.00
6 Weeks 51 ± 14 50 ± 13
Change -1 ± 11 (P = 0.53) -2 ± 10 (P = 0.15) 0.63
Triglycerides (mg/dL)
Baseline 132 ± 52 132 ± 52 1.00
6 Weeks 118 ± 47 116 ± 50
Change -14 ± 37 (P = 0.02) -18 ± 43 (P = 0.03) 0.83
Total Cholesterol to High Density Lipoprotein Ratio
Baseline 5.0 ± 1.3 5.0 ± 1.3 1.00
6 Weeks 5.0 ± 1.2 4.8 ± 1.3
Change -0.06 ± 0.66 (P = 0.54) -0.21 ± 0.82 (P = 0.11) 0.38
Body composition
Weight (kg)
Baseline 81 ± 19 81 ± 19 1.00
6 Weeks 82 ± 18 82 ± 18
Change 0.4 ± 2.3 (P = 0.33) 0.7 ± 2.4 (P = 0.08) 0.52
Body Mass Index (kg/m2)
Baseline 29.2 ± 4.5 29.2 ± 4.5 1.00
6 Weeks 29.3 ± 4.3 29.5 ± 4.5
Change 0.2 ± 0.8 (P = 0.13) 0.4 ± 0.9 (P = 0.04) 0.56
Values are mean ± SD; p-value obtained from ANOVA for repeated measurements except otherwise stated; p-values in parenthesis indicate 
within-group p-values; *p-value obtain from student ttest; Change = 6 Weeks - Baseline; † obtained from generalized linear models, 
controlling for age, blood pressure, LDL and BMINjike et al. Nutrition Journal 2010, 9:28
http://www.nutritionj.com/content/9/1/28
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ables potentially confounding the correlation between
nutrient intakes and endothelial responses included phys-
ical activity, vasoactive medication use, and genetic fac-
tors. Unmeasured or inaccurately measured dietary
intake data could also have confounded results. Three-
day food diaries, used to track dietary intake, did not
indicate any significant unintended changes in overall
dietary pattern, although changes in diet or behavior that
were not captured may have impacted findings. Adjust-
ment for potential confounders was managed through
application of strict eligibility criteria, randomization,
and crossover design. Also of note, the intended provoca-
tion of endothelial dysfunction by a single meal high in
saturated fat failed to demonstrate a deleterious effect.
Finally, endothelial function was measured only one time
after treatment assignments and not monitored for a pro-
longed time.
Conclusions
In light of the persistent uncertainties and lack of obser-
vational evidence regarding the effects of egg consump-
tion on serum cholesterol and cardiac risk, the
application of this methodology and technology in fur-
ther studies is appropriate, and very much needed. Short
of a randomized controlled trial of egg consumption and
cardiovascular events, endothelial function testing offers
one of the best available means to evaluate the role of egg
ingestion on cardiac risk. To date, the evidence generally
mitigates against an association between moderate egg
consumption and increased cardiac risk. Further testing
in at-risk samples, including individuals with established
coronary disease, is now justified to clarify the place of
eggs in a judicious and heart-healthy diet.
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